A phase I trial of GRN163L (GRN), a first-in-class telomerase inhibitor, in advanced solid tumors

被引：0
|
作者：
Ratain, M. J.
Benedetti, F. M.
Janisch, L.
Khor, S.
Schilsky, R. L.
Cohen, E. E.
Maitland, M. L.
Elias, L.
LoRusso, P. M.
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
[2] Geron Corp, Menlo Pk, CA USA
[3] Wayne State Univ, Detroit, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3581
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Investigating the role of BRCA1 in sensitivity to GRN163L, a telomerase template antagonist
    Phipps, Elizabeth A.
    Gryaznov, Sergei
    Herbert, Brittney-Shea
    CANCER RESEARCH, 2012, 72
  • [22] Effect of a novel telomerase inhibitor, Grn163l, on growth of Barrett's esophageal adenocarcinoma cells in vitro and in vivo
    Shammas, Masood A.
    Qazi, Aamer
    Batchu, Ramesh B.
    Bertheau, Robert C.
    Wong, Jason Y.
    Rao, Manjula Y.
    Bryant, Christopher S.
    Kumar, Sanjeev
    Prasad, Madhu
    Ponnazhagan, Selvarangan
    Chanda, Diptiman
    Steffes, Christopher P.
    Munshi, Nikhil C.
    De Vivo, Immaculata
    Beer, David G.
    Gryaznov, Sergei
    Weaver, Donald W.
    Goyal, Raj K.
    GASTROENTEROLOGY, 2008, 134 (04) : A741 - A741
  • [23] Imetelstat sodium (GRN163L), a telomerase inhibitor: tolerability, pharmacokinetics and pharmacodynamic activity using an intermittent once every four weeks dosing schedule in patients with advanced solid tumors
    Ratain, M. J.
    Kelsey, S.
    Janisch, L.
    Smith, J.
    Go, N.
    Lin, T.
    Maitland, M. L.
    Kindler, H. L.
    LoRusso, P. M.
    EJC SUPPLEMENTS, 2010, 8 (07): : 123 - 123
  • [24] Investigating the role of BRCA1 in sensitivity to GRN163L, a telomerase template antagonist
    Phipps, E. A.
    Gryaznov, S. M.
    Herbert, B-S
    CANCER RESEARCH, 2012, 72
  • [25] Oligonucleotide conjugate GRN163L targeting human telomerase as potential anticancer and antimetastatic agent
    Gryaznov, Sergei M.
    Jackson, Shalmica
    Dikmen, Gunnur
    Harley, Calvin
    Herbert, Brittney-Shea
    Wright, Woodring E.
    Shay, Jerry W.
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2007, 26 (10-12): : 1577 - 1579
  • [26] The novel telomerase inhibitor GRN163L targets drug-resistant cancer stem cells in multiple myeloma
    Matsui, William H.
    Wang, Qiuju
    Brennan, Sarah
    Meeker, Alan
    Tressler, Robert
    Harley, Calvin
    Huff, Carol Ann
    Smith, B. Douglas
    Jones, Richard J.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3366S - 3366S
  • [27] Telomerase template antagonist GRN163L disrupts telomere maintenance, tumor growth, and metastasis of breast cancer
    Hochreiter, Amelia E.
    Xiao, Hongling
    Goldblatt, Erin M.
    Gryaznov, Sergei M.
    Miller, Kathy D.
    Badve, Sunil
    Sledge, George W.
    Herbert, Brittney-Shea
    CLINICAL CANCER RESEARCH, 2006, 12 (10) : 3184 - 3192
  • [28] New therapeutic approach for brain tumors: Intranasal delivery of telomerase inhibitor GRN163
    Hashizume, Rintaro
    Ozawa, Tomoko
    Gryaznov, Sergei M.
    Bollen, Andrew W.
    Lamborn, Kathleen R.
    Frey, William H., II
    Deen, Dennis F.
    NEURO-ONCOLOGY, 2008, 10 (02) : 112 - 120
  • [29] Telomerase inhibitor GRN163L demonstrates anti-tumor efficacy in small cell lung carcinoma models and an ovarian cancer model
    Go, Ning F., Sr.
    Li, Yong J.
    Chin, Allison C.
    Harley, Calvin B.
    Gryaznov, Sergei M.
    Tressler, Robert L.
    CANCER RESEARCH, 2006, 66 (08)
  • [30] Novel and potent telomerase antagonist (GRN163L) inhibits telomerase activity, resulting in telomere shortening and apoptosis of multiple myeloma cells.
    Shammas, MA
    Koley, H
    Tassone, P
    Neri, P
    Protopopov, A
    Gryaznov, S
    Chin, A
    Anderson, KC
    Munshi, NC
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 586S - 586S
12345